AIkido Pharma, Inc.(NASDAQ : SPEX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||-0.92%||725.15||2.6%||$747.78m|
|GILD||Gilead Sciences, Inc.||-0.59%||64.57||1.0%||$546.83m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.23%||294.95||1.9%||$424.62m|
|SNSS||Sunesis Pharmaceuticals, Inc.||1.99%||4.10||0.7%||$286.61m|
|SAVA||Cassava Sciences, Inc.||-5.74%||39.92||0.0%||$178.80m|
|BMRN||BioMarin Pharmaceutical, Inc.||-3.53%||88.26||4.2%||$92.55m|
|PRTA||Prothena Corp. Plc||-3.14%||56.73||13.8%||$76.72m|
|CRSP||CRISPR Therapeutics AG||-4.20%||62.52||0.6%||$74.93m|
AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.